Status:
TERMINATED
Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery
Lead Sponsor:
Medstar Health Research Institute
Collaborating Sponsors:
Amenity Health, Inc.
Conditions:
Obesity, Morbid
Wound Infection
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Obese women are more likely have a cesarean delivery and develop subsequent wound complications than normal weight women. Negative pressure wound therapy (NPWT) has been shown to improve surgical woun...
Detailed Description
Obese women are more likely to be delivered by cesarean than normal weight women and are at increased risk for operative morbidity including wound complications. Negative pressure wound therapy (NPWT)...
Eligibility Criteria
Inclusion
- Body Mass Index ≥40 kg/m2 at time of delivery
- Delivered by cesarean delivery
- 18 years or later
Exclusion
- Chorioamnionitis
- Silver allergy
- Inability to follow up
Key Trial Info
Start Date :
October 3 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03269968
Start Date
October 3 2017
End Date
June 30 2019
Last Update
October 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010